Human Interferon in Viral Diseases

Abrams, 1986, Alpha interferon therapy of AIDS-associated Kaposi's sarcoma. AIDS Clinic, San Francisco General Hospital, California, Semin Oncol, 13, 43 Actis, 1986, Treatment of patients with delta hepatitis using interferon, (Letter) Arch Intern Med, 146, 2081, 10.1001/archinte.1986.00360220263047 Adams, 1984, Interferon treatment of adenoviral con junctivitis, Am J Ophthalmol, 98, 429, 10.1016/0002-9394(84)90125-9 Alawattegama, 1984, (Letter) Lancet, 1, 1468 Arnaoudova, 1976, Treatment and prevention of acute respiratory virus infections in children with leukocytic interferon, Rev Roum Med Virol, 27, 89 Arvin, 1976, Effect of leukocyte interferon on urinary excre tion of cytomegalovirus by infants, J Infect Dis, 233, 205, 10.1093/infdis/133.Supplement_2.A205 Arvin, 1978, Fluman leucocyte interferon in the treatment of varicella in children with cancer: A preliminary controlled trial, Antimicrob Agents Chemother, 13, 605, 10.1128/AAC.13.4.605 Arvin, 1982, Human leukocyte interferon for the treatment of varicella in children with cancer, N Engl J Med, 306, 761, 10.1056/NEJM198204013061301 Baer, 1977, Successful prophylaxis against rabies in mice and rhesus monkeys-the interferon system and vaccine, J Infect Dis, 136, 286, 10.1093/infdis/136.2.286 Bartram, 1982, Subacute sclerosing panencephalitis in a brother and sister. Therapeutic trial of fibroblast interferon, Eur J Pediatr (Ger many, West), 138, 187, 10.1007/BF00441152 Behan, 1981, Interferon in treatment of subacute sclerosing panencephalitis, Lancet, 1, 1059, 10.1016/S0140-6736(81)92228-5 Berg, 1980, SDA-polyacrylamide gel electrophoresis of purified human leu cocyte interferon and the antiviral and anticellular activities of the different inter feron species, J Gen Virol, 50, 441, 10.1099/0022-1317-50-2-441 Berman, 1986, Treatment of verrucae vulgaris with α2 interferon, J Infect Dis, 154, 328, 10.1093/infdis/154.2.328 Betts, 1983, A field trial of intranasal interferon Billiau, 1979, Human fibroblast interferon for clinical trials: Pharmacokinetics and tolerability in experimental animals and humans, Antimi-crob Agents Chemother, 16, 56, 10.1128/AAC.16.1.56 Bino, 1982, The kidney is the main site of interferon degrada tion, J Interferon Res, 2, 301, 10.1089/jir.1982.2.301 Blalock, 1980, Common pathways of interferon and hormonal action, Nature (London), 283, 406, 10.1038/283406a0 Bocci, 1982, The kidney is the main site of interferon catabolism, J Interferon Res, 2, 309, 10.1089/jir.1982.2.309 Bocci, 1982, The role of liver in the catabolism of human α- and β-interferon, J Gen Virol, 60, 397, 10.1099/0022-1317-60-2-397 Bocci, 1985, Colorectal administration of human inter-feron-α, Int J Pharmaceu, 24, 109, 10.1016/0378-5173(85)90148-6 Bornholt, 1983, Interferon therapy for laryngeal papillomatosis in adults, Arch Otolar yngol, 109, 550, 10.1001/archotol.1983.00800220056014 Bornholt, 1986, Light microscopical features of interferon-alpha-treated laryngeal papillomatosis in adults, Acta Otolaryngol (Stockh), 102, 131, 10.3109/00016488609108657 Bye, 1985, Use of interferon in the management of patients with subacute sclerosing panencephalitis, Dev Med Child Neurol, 27, 170, 10.1111/j.1469-8749.1985.tb03766.x Byrne, 1986, The effect of interferon on human papillomaviruses associated with cervical intraepithelial neoplasia, Brit J Obstet Gynecol, 93, 1136, 10.1111/j.1471-0528.1986.tb08634.x Came, 1976, Sensitivity of rhinoviruses to human leukocyte and fibroblast interferons, J Infect Dis, 133, A136, 10.1093/infdis/133.Supplement_2.A136 Cantell, 1960, Effect of interferon on experimental vaccinia and herpes simplex virus infections in rabbits eyes, Lancet, 2, 682, 10.1016/S0140-6736(60)91751-7 Cantell, 1974, Human leukocyte interferon: production, purification, stability, and animal experiments, 35 Cantell, 1974, Circulating human interferon after intramuscular injection into animals and man, J Gen Virol, 25, 453, 10.1099/0022-1317-25-3-453 Carter, 1980, Interferon and hepatitis infection: current results and possible amplification of the therapeutic response, 693 Carreno, 1984, Long-term treatment of chronic hepatitis B virus (HBV) infection with recombinant leukocyte A interferon (rIFN-αA): A pilot study, (Abstract) Antiviral Res, 1, 101 Cesario, 1977, The effect of body fluids on polynucleotide-induced fibroblast interferon and virus-induced leukocyte interferon, Proc Soc Exp Biol Med, 155, 583, 10.3181/00379727-155-39855 Cheeseman, 1979, Controlled clinical trial of prophy lactic human-leukocyte interferon in renal transplantation. Effect of cytomegalo virus and herpes simplex virus infection, N Engl J Med, 300, 1345, 10.1056/NEJM197906143002401 Cheeseman, 1980, Interferon and BK papovavirus-clin ical and laboratory studies, J Infect Dis, 141, 157, 10.1093/infdis/141.2.157 Chou, 1984, Alpha-interferon administration in cyto megalovirus retinitis, Antimicrob Agents Chemother, 25, 25, 10.1128/AAC.25.1.25 Colburn, 1983, Pharmacokinetics of recombinant leukocyte A interferon following single doses to humans, Clin Pharmacol Ther, 33, 114 Colin, 1983, Combination therapy for dendritic keratitis with human leukocyte infusion and acyclovir, Am J Ophthalmol, 95, 346, 10.1016/S0002-9394(14)78303-5 Coster, 1977, Clinical experience of human leucocyte interferon in the management of herpetic keratitis, Trans Ophthalmol Soc UK, 97, 324 Davies, 1983, Comparative intranasal pharmacoki netics of interferon using two spray systems, J Interferon Res, 3, 443, 10.1089/jir.1983.3.443 Davis, 1986, Interferon in viral hepatitis: Role in pathogenesis and treatment, Hepatology, 6, 1038, 10.1002/hep.1840060537 De Clercq, 1975, Intrathecal administration of interferon in neonatal herpes, J Pediatr, 86, 736, 10.1016/S0022-3476(75)80360-X DeKoning, 1982, Combination therapy for dendritic keratitis with human leucocyte interferon and trifluorothymidine, Br J Oph thalmol, 66, 509, 10.1136/bjo.66.8.509 De Koning, 1983, Combination therapy for dendritic keratitis with acyclovir and α-interferon, Arch Ophthalmol, 101, 1866, 10.1001/archopht.1983.01040020868006 De la Pena, 1978, Combined therapy of human interferon (HI) and secretory immunoglobulin (S-IgA) in the treatment of human herpetic keratitis, Biomedicine, 28, 104 De Maeyer, 1981, Interferons as regulatory agents of the im mune system, CRC Crit Rev Immunol, 2, 167 Desmyter, 1976, Administration of human fibroblast interferon in chronic hepatitis-B infection, Lancet, 2, 645, 10.1016/S0140-6736(76)92460-0 Dianzani, 1977, The continued presence of interferon is not required for activation of cells by interferon, Proc Soc Exp Biol, 155, 562, 10.3181/00379727-155-39851 Dinarello, 1984, Mechanisms of fever induced by recombinant human interferon, J Clin Invest, 74, 906, 10.1172/JCI111508 Dolen, 1979, Fibroblast interferon treatment of a patient with chronic active hepatitis. Increased number of circulating T lympho cytes and elimination of rosette-inhibitory factor, Am J Med, 67, 127, 10.1016/0002-9343(79)90088-3 Dolin, 1983, Intranasally administered rIFN-α as prophylaxis against experimentally induced influenza in man, Proceedings of the 13th International Congress of Chemotherapy Dooley, 1986, Pilot study of recombinant human alpha interferon for chronic type B hepatitis, Gastroenterology, 90, 150, 10.1016/0016-5085(86)90087-9 Douglas, 1985, Intranasal interferon-α 2 prophylaxis of natural respiratory virus infection, J Infect Dis, 151, 731, 10.1093/infdis/151.4.731 Douglas, 1986, Prophylactic efficacy of intranasal alpha interferon against rhinovirus infections in the family setting, N Engl J Med, 314, 65, 10.1056/NEJM198601093140201 Douglas, 1986, The effect of asymptomatic infection with HTLV-III on the response of anogenital warts to intralesional treatment with re combinant α2 interferon, J Infect Dis, 154, 331, 10.1093/infdis/154.2.331 Dusheiko, 1985, Recombinant leukocyte interferon treatment of chronic hepatitis B, Hepatology, 5, 556, 10.1002/hep.1840050406 Einhorn, 1983, Systemic interferon alpha treatment of human condyloma acuminata, Acta Obstet Gynecol Scand, 62, 285, 10.3109/00016348309155812 Eisenberg, 1986, Preliminary trial of recombinant fibroblast interferon in chronic hepatitis B virus infection, Antimicrob Agents Chemother, 29, 122, 10.1128/AAC.29.1.122 Emodi, 1975, Circulating interferon in man after adminis tration of exogenous human leukocyte interferon, J Natl Cancer Inst, 54, 1045 Emodi, 1975, Human interferon therapy for herpes zoster in adults, Scand J Infect Dis, 7, 1, 10.3109/inf.1975.7.issue-1.01 Emodi, 1976, Effect of human exogenous leukocyte inter feron in cytomegalovirus infections, J Infect Dis, 133, 199, 10.1093/infdis/133.Supplement_2.A199 Emodi, 1983, Preliminary results on tolerance and toxicity tests using human fibroblast interferon (beta-type) in patients with herpes genitalis infections, Int J Clin Pharmacol Res (Switzerland), 3, 275 Epstein, 1981, Interferon as a model lymphokine, Fed Proc., 40, 56 Eron, 1986, Interferon therapy for condylomata acuminata, N Engl J Med, 315, 1059, 10.1056/NEJM198610233151704 Eron, 1986, Interferon in the prevention of genital herpes recurrence, Antimicrob Agents Chemother, 30, 608, 10.1128/AAC.30.4.608 Falcoff, 1966, Production en masse, purification partielle et caractérisation d'un interferon destine a des essais therapeutiques humains, Ann Inst Pasteur, 111, 562 Farr, 1984, Intranasal interferon-α 2 for prevention of natural rhinovirus colds, Antimicrob Agents Chemother, 26, 31, 10.1128/AAC.26.1.31 Floyd-Smith, 1981, Interferon action: RNA cleavage pattern of a (2′-5′) oligoadenylate-dependent endonuclease, Science, 212, 1030, 10.1126/science.6165080 Foy, 1986, Efficacy of alpha2-interferon against the common cold, (Letter) N Engl J Med, 315, 513, 10.1056/NEJM198608213150811 Frederick, 1985, Viral infections and cell-mediated immunity in immunodeficient homosexual men with Kaposi's sarcoma treated with human lymphoblastoid interferon, J Infect Dis, 152, 162, 10.1093/infdis/152.1.162 Friedman-Kien, 1986, Treatment of recurrent genital herpes with topical alpha interferon gel combined with nonoxynol 9, J Am Acad Dermatol, 15, 989, 10.1016/S0190-9622(86)70262-4 Gall, 1986, Efficacy of human lymphoblastoid interferon in the therapy of resistant condyloma acuminata, Obstet Gynecol, 67, 643, 10.1097/00006250-198605000-00008 Garotta, 1986, Functional antagonism between type I and type II interferons on human macrophages, Biochem Biophys Res Commun, 140, 948, 10.1016/0006-291X(86)90727-8 Geffen, 1984, Intralesional administration of large doses of human leukocyte interferon for the treatment of condyloma acuminata, J Infect Dis, 150, 612, 10.1093/infdis/150.4.612 Geha, 1986, A trial of intranasal alpha interferon in asth matic children, (Abstract) J Allergy Clin Immunol, 77, 160 Gelmann, 1985, Human lymphoblastoid interferon treat ment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters, Am J Med, 78, 737, 10.1016/0002-9343(85)90276-1 Gibson, 1985, Pharmacokinetics of recombinant leuko cyte A interferon following various routes and modes of administration to the dog, J Interferon Res, 5, 403, 10.1089/jir.1985.5.403 Gibson, 1986, Treatment of common and plantar viral warts with human lymphoblastoid interferon-a-pilot studies with intralesional, intramuscular and dermojet injections, Br J Dermatol, 115, 76, 10.1111/j.1365-2133.1986.tb02113.x Gibson, 1984, Interferon in the treatment of persistent viral warts, Der-matologica, 169, 47 Gobel, 1981, Comparison of human fibroblast and leukocyte interferon in the treatment of severe laryngeal papillomatosis in children, Eur J Pediatr, 137, 175, 10.1007/BF00441312 Goepfert, 1982, Leukocyte interferon in patients with juvenile laryngeal papillomatosis, Ann Otol Rhinol Laryngol, 91, 431, 10.1177/000348948209100422 Greenberg, 1976, Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis, N Engl J Med, 295, 517, 10.1056/NEJM197609022951001 Greenberg, 1978, Antiviral activity of intranasally applied human leukocyte interferon, Antimicrob Agents Chemother, 14, 596, 10.1128/AAC.14.4.596 Greenberg, 1980, Exogenous interferon: Stability and phar macokinetics, 57 Greenberg, 1982, Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus, J Infect Dis, 145, 542, 10.1093/infdis/145.4.542 Groopman, 1984, Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syn drome, Ann Intern Med, 100, 671, 10.7326/0003-4819-100-5-671 Gutterman, 1982, Recombinant leukocyte A interferon: phar macokinetics, single-dose tolerance, and biologic effects in cancer patients, Ann Intern Med, 96, 549, 10.7326/0003-4819-96-5-549 Haglund, 1981, Interferon therapy in juvenile laryngeal papillomatosis, Arch Otolaryngol, 107, 327, 10.1001/archotol.1981.00790420001001 Harmon, 1976, Effect of human nasal secretions on the antiviral activity of human fibroblast and leukocyte interferon, Proc Soc Exp Biol Med, 152, 598, 10.3181/00379727-152-39448 Harmon, 1977, Human nasal epithelial cell culture system: evaluation of response to human interferons, Infect Immunol, 16, 480, 10.1128/IAI.16.2.480-485.1977 Harmon, 1980, Rapid onset of the interferon-induced antiviral state in human nasal epithelial and foreskin fibroblast cells, Proc Soc Exp Biol Med, 164, 146, 10.3181/00379727-164-40838 Haverkos, 1980, Follow-up of interferon treatment of herpes simplex, N Engl J Med, 303, 699, 10.1056/NEJM198009183031211 Hayden, 1983, Intranasal interferon a2 for prevention of rhinovirus infection and illness, J Infect Dis, 148, 543, 10.1093/infdis/148.3.543 Hayden, 1983, Human tolerance and histopathologic effects of long-term-α2, J Infect Dis, 148, 914, 10.1093/infdis/148.5.914 Hayden, 1984, Intranasal interferon-a2 treatment of experimental rhinoviral colds, J Infect Dis, 150, 174, 10.1093/infdis/150.2.174 Hayden, 1985, Prophylactic efficacy and tolerance of low-dose intranasal interferon-alpha, in natural respiratory viral infections, Antiviral Res, 5, 111, 10.1016/0166-3542(85)90037-3 Hayden, 1986, Prevention of natural colds by contact prophylaxis with intranasal alpha-2 interferon, N Engl J Med, 314, 71, 10.1056/NEJM198601093140202 Heidemann, 1984, Gunstigerer verlauf des herpes zoster be iimmunsupprimierten patienten unter behandlung mit fibroblasteninterferon, Onkologie (Switzerland), 7, 210 Herzog, 1986, Intranasal interferon (IFN-aA, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled field study, Antiviral Res, 6, 171, 10.1016/0166-3542(86)90011-2 Higgins, 1983, Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers, Antimicrob Agents Chemother, 24, 713, 10.1128/AAC.24.5.713 Higgins, 1986, Interferon-ß ser as prophylaxis against experimental rhinovirus infection in volunteers, J Interferon Res, 6, 153, 10.1089/jir.1986.6.153 Hilfenhaus, 1977, Administration of human interferon to rabies virus-infected monkeys after exposure, J Infect Dis, 135, 846, 10.1093/infdis/135.5.846 Hirsch, 1983, Effects of interferon-alpha on cytomega lovirus reactivation syndromes in renal transplant recipients, N Engl J Med, 308, 1489, 10.1056/NEJM198306233082501 Ho, 1974, Interferon administered in the cerebrospinal space and its effect on rabies in rabbits, Infect Immunol, 9, 286, 10.1128/IAI.9.2.286-293.1974 Ho, 1981, Intralesional treatment of warts with interferon-α and its long-term effects on NK cell activity, 361 Ho, 1985, Recombinant human interferon alpha A suppresses HTLV-III replication in vitro, Lancet, 1, 602, 10.1016/S0140-6736(85)92144-0 Hochkeppel, 1982, Monoclonal activity against human IFN-, Nature, 296, 258, 10.1038/296258a0 Honigsberger, 1983, Neurological effects of recombinant human interferon, Br Med J, 286, 719, 10.1136/bmj.286.6366.719-a Hoofnagle, 1985, Treatment of chronic delta hepatitis with recombinant human alpha interferon, Gastroenterology, 88, 1665 Hoofnagle, 1985, Randomized controlled trial of a four month course of recombinant human alpha interferon in patients with chronic type B hepatitis, Hepatology, 5, 1033 Hoofnagle, 1985, 493 Hoofnagle, 1986, Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon, N Engl J Med, 315, 1575, 10.1056/NEJM198612183152503 Hooks, 1979, Immune interferon in the circulation of patients with autoimmune disease, N Engl J Med, 301, 5, 10.1056/NEJM197907053010102 Horn MEC, Gregg I: Role of viral infection and host factors in acute episodes of asthma and chronic bronchitis. Chest 63: 44S Huhti, 1974, Association of viral and mycoplasma infections with exacerbations of asthma, Ann Allergy, 33, 145 Huttenlocher, 1986, Intrathecal interferon in subacute sclerosing panencephalitis, Ann Neurol, 19, 303, 10.1002/ana.410190317 Ida, 1977, Enhancement of IgE-mediated histamine release from human basophils by viruses: Role of Interferon, J Exper Med, 145, 892, 10.1084/jem.145.4.892 Ikeda, 1986, Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life, Hepa tology, 6, 962 Ikic, 1975, Therapy of herpetic gingivostomatitis in children with human leukocytic interferon, 203 Ikic, 1975, Treatment with human leukocyte interferon, 183 Ikic, 1975, Therapy and prevention of epidemic keratocon junctivitis with human leukocyte interferon, 189 Ikic, 1975, Treatment of labial and genital herpes with human leukocytic interferon, 195 Ikic, 1975, Preliminary study of the effect of human leukocytic interferon on condylomata acuminata in women, 223 Ikic, 1975, Therapeutical effect of human leuko cyte interferon incorporated into ointment and cream on condylomata acuminata, 235 Ikossi-O'Connor, 1986, Interferon inactivator (s) in pa tients with AIDS and AIDS-related Kaposi's Sarcoma, Am J Med, 81, 783, 10.1016/0002-9343(86)90345-1 Imanishi, 1980, The preventive effect of human interferon alpha preparation on upper respiratory disease, J Interferon Res, 1, 169, 10.1089/jir.1980.1.169 Ingimarsson, 1979, Side effects of long-term treatment with human leukocyte interferon, J Infect Dis, 140, 560, 10.1093/infdis/140.4.560 Ingimarsson, 1981, Immune reactions and long-term therapy with human leukocyte interferon, Acta Med Scand, 209, 17, 10.1111/j.0954-6820.1981.tb11545.x Isaacs, 1957, Virus interference. I. The interferon, Proc R Soc London (Biol), 147, 258 Isaacs, 1957, Virus interference. II. Some properties of interferon, Proc R Soc London (Biol), 147, 268 Isaacs, 1958, Mode of action of interferon, Nature, 182, 1073, 10.1038/1821073a0 Isaacs, 1959, Inhibition by interferon of the growth of vaccinia virus in the rabbit skin, Lancet, 2, 324, 10.1016/S0140-6736(59)91361-3 Isaacs, 1981, Deficient production of leucocyte interferon interferon-a) in vitro and in vivo in children with recurrent respiratory tract in fections, Lancet, 2, 950, 10.1016/S0140-6736(81)91153-3 Isomura, 1982, The preventive effect of human interferon alpha on influenza infection: modification of clinical manifestations of influenza in children in a closed community, Biken Journal, 25, 131 Iwarson, 1980, Interferon treatment in acute hepatitis B infection with prolonged course, Scand J Infect Dis, 12, 233, 10.3109/inf.1980.12.issue-3.13 Jacobs, 1985, Intrathecal interferon in the treatment of multiple sclerosis. Patient follow-up, Arch Neurol, 42, 841, 10.1001/archneur.1985.04060080019009 Jacobs, 1986, Multicenter double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis, Lancet, 2, 1411, 10.1016/S0140-6736(86)92730-3 Jicha, 1986, Effects of recombinant human leukocyte interferon treatment on endogenous interferon production in patients with chronic type-B hepatitis, J Interferon Res, 6, 13, 10.1089/jir.1986.6.13 Johnson, 1976, Recovery of applied human leuko cyte interferon from the nasal mucosa of chimpanzees and humans, J Clin Micro biol, 4, 106, 10.1128/jcm.4.1.106-107.1976 Jones, 1962, Vaccinial keratitis treated with inter feron, Lancet, 1, 875, 10.1016/S0140-6736(62)91908-6 Jones, 1976, Clinical trials of topical interferon therapy of ulcerative viral keratitis, J Infect Dis, 133, 169, 10.1093/infdis/133.Supplement_2.A169 Jones, 1976, Topical therapy of ulcerative herpetic kera titis with human interferon, Lancet, 2, 128, 10.1016/S0140-6736(76)92850-6 Jones, 1982, Interferon activates macrophages to produce plasminogen activator, J Interferon Res, 2, 377, 10.1089/jir.1982.2.377 Jordan, 1974, Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating antiviral activity, and host responses to infection, J Infect Dis, 130, 541 Kataoka, 1984, A case of subacute sclerosing panencephalitis (SSPE) treated with alpha-type interferon (IFN), Brain Dev, 6, 210 Kataoka, 1984, Inosiplex and interferon treatment in 2 patients with SSPE, J Brain Dev, 6, 211 Kaufman, 1972, Difference in interferon response from ocular virus infection in rabbits and monkeys, Am J Ophthalmol, 74, 89, 10.1016/0002-9394(72)91131-2 Kaufman, 1976, Human leukocyte interferon for the prevention of recurrences of herpetic keratitis, J Infect Dis, 133, 165, 10.1093/infdis/133.Supplement_2.A165 Kiderlen, 1984, Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune in terferon, Eur J Immunol, 14, 964, 10.1002/eji.1830141019 Kingham, 1978, Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon, Gut, 19, 91, 10.1136/gut.19.2.91 Kita, 1983, Intraventricular administration of interferon in a patient with subacute sclerosing panencephalitis, J Int Symposium Interferons Abstracts (Japan) Kobza, 1975, Treatment of herpes infection with human exoge nous interferon, Lancet, 1, 1343, 10.1016/S0140-6736(75)92350-8 Koskiniemi, 1982, Trial with human leukocyte interferon and vidarabine in herpes simplex virus encephalitis: Diagnostic and therapeutic problems, Acta Med Scand (Suppl), 668, 150 Kovanen, 1980, Failure of interferon to modify Creutzfeldt-Jakob disease, Br Med J, 29, 902, 10.1136/bmj.280.6218.902-a Krasikova, 1977, Interferongenesis and efficacy of refined leukocytic interferon use in acute respiratory viral infections in premature children, Pediatriia, 5, 42 Krown, 1983, Preliminary observations on the ffect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma, N Engl J Med, 308, 1071, 10.1056/NEJM198305053081806 Kuhls, 1986, Suppression of recurrent genital herpes simplex virus infection with recombinant α2 interferon, J Infect Dis, 154, 437, 10.1093/infdis/154.3.437 Larsson, 1976, Administration of interferon to an infant with congenital rubella syndrome involving persistent viremia and cutaneous vas culitis, Acta Paediatr Scand, 65, 105, 10.1111/j.1651-2227.1976.tb04415.x Lengyel, 1982, Biochemistry of interferons and their actions, Ann Rev Biochem, 51, 251, 10.1146/annurev.bi.51.070182.001343 Levin, 1985, Interferon treatment of poliomyelitis, J Infect Dis, 151, 745, 10.1093/infdis/151.4.745 Lodemann, 1984, (2′-5′) Oligo (A) synthetase as a monitor of interferon action in juvenile laryngeal papillomatosis, J Interferon Res, 4, 283, 10.1089/jir.1984.4.283 Lok, 1984, Thrice weekly lymphoblastoid inter feron is effective in inhibiting hepatitis B virus replication, Liver, 4, 45, 10.1111/j.1600-0676.1984.tb00906.x Lok, 1985, A randomized study of the effects of adenine arabinoside 5′-monophosphate (short and long courses) and lymphoblas toid interferon on hepatitis B virus replication, Hepatology, 5, 1132, 10.1002/hep.1840050612 Lonberg, 1985, Sequential and simultaneous alpha 2 inter feron (IFN) and VP-16 in epidemic Kaposi's sarcoma (KS), Proc Am Soc Clin Oncol, 4, 6 Lundquist, 1984, Interferon therapy in juvenile laryn geal papillomatosis, Otolaryngol, 92, 386, 10.1177/019459988409200403 McCabe, 1984, Effect of murine interferon gamma on murine toxoplasmosis, J Infect Dis, 150, 961, 10.1093/infdis/150.6.961 McCabe, 1983, Interferon and laryngeal papillomatosis: the Iowa experi ence, Ann Otol Rhinol Laryngol, 92, 2, 10.1177/000348948309200102 McGill, 1977, Optimal usage of exogenous human interferon for prevention or therapy of herpetic keratitis, Trans Ophthalmol Soc UK, 97, 324 McGill, 1985, Viral keratitis, Br Med Bui, 41, 351, 10.1093/oxfordjournals.bmb.a072075 Marcovici, 1983, Human fibroblast interferon therapy in patients with condyloma accuminata, Isr J Med Sci, 19, 104 Matsamura, 1983, Therapeutic effects of a low dosage of human leucocyte interferon in chronic type B hepatitis B virus infection, Digestion, 26, 205, 10.1159/000198891 Mendelson, 1986, Effect of recombinant interferon alpha 2 on clinical course of first episode genital herpes infection and subsequent recur rences, Genitourin Med, 62, 97 Merigan, 1973, Inhibition of respiratory virus infection by locally applied interferon, Lancet, 1, 563, 10.1016/S0140-6736(73)90714-9 Merigan, 1978, Human leukocyte interferon for the treat ment of herpes zoster in patients with cancer, N Engl J Med, 298, 981, 10.1056/NEJM197805042981801 Merigan, 1981, Short-course human leukocyte inter feron in treatment of herpes zoster in patients with cancer, Antimicrob Agents Chemother, 19, 193, 10.1128/AAC.19.1.193 Merigan, 1984, Human leukocyte interferon adminis tration to patients with symptomatic and suspected rabies, Ann Neurol, 16, 82, 10.1002/ana.410160116 Merritt, 1986, Modulation of 2′, 5′-oligo-adenylate synthe tase in patients treated with alpha-interferon: Effects of dose, schedule, and route of administration, J Interferon Res, 6, 189, 10.1089/jir.1986.6.189 Meurs, 1985, Combination therapy of recombinant human alpha 2 interferon and acyclovir in the treatment of herpes simplex keratitis. Proceedings of the 1st International TNO Conference on Antiviral Research. Rotterdam, Anti viral Res (Suppl), 1, 225 Meyers, 1980, Toxicity and efficacy of human leu kocyte interferon for treatment of cytomegalovirus pneumonia after marrowtransplantation, J Infect Dis, 141, 555, 10.1093/infdis/141.5.555 Meyers, 1982, Treatment of cytomegalovirus pneu monia after marrow transplant with combined vidarabine and human leukocyte interferon, J Infect Dis, 146, 80, 10.1093/infdis/146.1.80 Meyers, 1983, Recombinant leukocyte A interferon for the treatment of serious viral infections after marrow transplant: A phase 1 study, J Infect Dis, 148, 551, 10.1093/infdis/148.3.551 Michaels, 1986, Intranasal interferon prophylaxis of viral infec tions in adult and pediatric asthmatic patients, (Abstract) J Allergy Clin Immunol, 77, 160 Minor, 1974, Viruses as precipitants of asthmatic attacks in children, J Am Med Assoc, 227, 292, 10.1001/jama.1974.03230160020004 Miller, 1982, Crystallization of recombinant human leukocyte interferon-α, Science, 215, 689, 10.1126/science.6173922 Mizutani, 1985, Treatment of subacute sclerosing panen cephalitis with human leukocyte interferon, Tohoku J Exp Med, 146 Moller, 1983, Treatment of dysplasia of the cervical epithelium with an interferon gel, Obstet Gynecol, 62, 625 Monte, 1986, Intranasal interferon-a2b for seasonal prophylaxis of respiratory infection, J Infect Dis, 154, 128, 10.1093/infdis/154.1.128 Muller, 1982, Long term treatment with human fibroblast interferon in chronic hepatitis B: Preliminary data of a controlled trial, 648 Munoz, 1984, Comparison of the antiviral action of different human inter ferons against DNA and RNA viruses, FEMS Microb Lett, 21, 105, 10.1016/0378-1097(84)90187-3 Muranaka, 1984, Studies on safety problem by skin tests using human beta interferon preparation, J Interferon Res, 4, 115, 10.1089/jir.1984.4.115 Naito, 1984, Concentrations of human interferons αandβ in rabbit body fluids, Int J Pharmaceu, 18, 117, 10.1016/0378-5173(84)90112-1 Nakashima, 1986, Recombinant human interferon gamma suppresses HTLV-III replication in vitro, Int J Cancer, 38, 433, 10.1002/ijc.2910380320 Nathan, 1983, Identification of interferon-y as the lympho kine that activates human macrophage oxidative metabolism and antimicrobial activity, J Exp Med, 158, 670, 10.1084/jem.158.3.670 Nathan, 1986, Local and systemic effects of intradermal recombinant interferon-y in patients with lepromatous leprosy, N Engl J Med, 315, 6, 10.1056/NEJM198607033150102 Negoro, 1980, Treatment of epidemic keratoconjunctivitis by human leukocyte interferon, Jpn J Ophthalmol, 24, 125 Neumann-Haefelin, 1977, Comparative evaluation of human leukocyte and fibroblast interferon in the prevention of herpes simplex virus keratitis in a monkey model, Infect Immunol, 17, 468, 10.1128/IAI.17.2.468-470.1977 Niimura, 1983, Intralesional human fibroblast interferon in common warts, J Dermatol (Tokyo, Japan), 10, 217, 10.1111/j.1346-8138.1983.tb01130.x Nishimura, 1984, Interferon therapy for SSPE, Brain Dev, 6, 210 Norris, 1986, The treatment of subacute sclerosing panencephalitis with interferon: A case report, J Neurol, 233, 102, 10.1007/BF00313855 Nuwer, 1971, Interferon clearance rate'decreased after repeated injections, J Gen Virol, 12, 191, 10.1099/0022-1317-12-2-191 Odajynk, 1984, Therapeutic trial of human gamma interferon (IFN) in patients with epidemic Kaposi's sarcoma (EKS), Proc Am Soc Clin Oncol, 3, 61 Omata, 1985, Recombinant leukocyte A interferon treatment in patients with chronic hepatitis B virus infections: Pharmacokinetics, tol erance, and biologic effects, Gastroenterology, 88, 870, 10.1016/S0016-5085(85)80002-0 O'Reilly, 1976, Effects of exogenous interferon in cytomeg alovirus infections complicating bone marrow transplantation, Clin Immun, 6, 51, 10.1016/0090-1229(76)90060-X Pahwa, 1983, Persistent cytomegalovirus infection: Asso-ciation with profound immunodeficiency and treatment with interferon, Clin Im munol Immunopathol, 28, 77, 10.1016/0090-1229(83)90190-3 Palleroni, 1984, Use of 125I-interferons in pharmacokinetic and tissue distribution studies, J Interferon Res, 4, 493, 10.1089/jir.1984.4.493 Pallin, 1976, Interferon in severe herpes simplex of cornea, Lancet, 2, 1187, 10.1016/S0140-6736(76)91581-6 Panitch, 1986, Subacute sclerosing panencepha litis: Remission after treatment with intraventricular interferon, Neuroloev, 36, 562, 10.1212/WNL.36.4.562 Pazin, 1979, Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root, N Engl J Med, 301, 225, 10.1056/NEJM197908023010501 Pazin, 1981, Effects of interferon-alpha on human warts, J Interferon Res, 2, 235, 10.1089/jir.1982.2.235 Peddinani, 1985, Human leukocyte gamma interferon in the treatment of epilepsy due to cytomegalovirus infection, Clin Therapeutics, 7, 696 Perrillo, 1985, Comparative efficacy of adenine arabinoside 5′ monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in treatment of chronic active hepatitis type B, Gastroenterology, 88, 780, 10.1016/0016-5085(85)90151-9 Peters, 1986, The interferon system in acute and chronic-viral hepatitis, VIII, 453 Phillpotts, 1983, An effective dosage regimen for prophy laxis against rhinovirus infection by intranasal administration of HuIFN-2, Anti viral Res, 3, 121, 10.1016/0166-3542(83)90034-7 Phillpotts, 1984, Intranasal lymphoblastoid interferon (“Wellferon”) prophylaxis against rhinovirus and influenza virus in volunteers, J Interferon Res, 4, 535, 10.1089/jir.1984.4.535 Picchietti, 1983, Intrathecal interferon in subacute sclerosing panencephalitis (SSPE), Neurology (NY), 33, 226 Preble, 1983, Biology of Disease. Interferon-induced alterations in cells: Relevance to viral and nonviral diseases, Lab Investiga, 49, 4 Preble, 1985, Interferon-induced 2′-5′ oligoadenylate synthe tase during interferon-a therapy in homosexual men with Kaposi s sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome, J Infect Dis, 152, 457, 10.1093/infdis/152.3.457 Purcell, 1976, Modification of chronic hepatitis-B virus infection in chimpanzees by administration of an interferon inducer, Lancet, 2, 757, 10.1016/S0140-6736(76)90598-5 Quesada, 1982, Clinical and immunological study of beta interferon by intramuscular route in patients with metastatic breast cancer, J In terferon Res, 2, 593, 10.1089/jir.1982.2.593 Real, 1984, Treatment of Kaposi's sarcoma with recombi nant leukocyte A interferon (rIFN-aA), Abstract ASCO, 1, 55 Reilly, 1986, Adenovirus type 8 keratoconjunctivitis-an outbreak and its treatment with topical human fibroblast interferon, J Hyg, Camb, Great Britain, 96, 557, 10.1017/S0022172400066365 Reunanen, 1978, Treatment of an SSPE case undergoing a sudden relapse after a ten-year remission, Acta Neurol Scand, 57, 239 Reznik, 1978, Trial preventive use of leukocyte inter feron in foci of acute respiratory diseases, Vopr Virusol, 6, 732 Rios, 1985, Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma with lymphoblastoid interferon, J Clin Oncol, 506, 10.1200/JCO.1985.3.4.506 Risk, 1979, The variable natural history of subacute sclerosing panen cephalitis: A study of 118 cases from the Middle East, Arch Neurol, 36, 610, 10.1001/archneur.1979.00500460044004 Rizzetto M, Rosina F, Saracco G, et al: Treatment of chronic delta hepatitis with lpha-2 recombinant interferon. J Hepatology (in press) Rohatiner, 1982, A phase 1 study of human lymphoblas toid interferon administered by continuous intravenous infusion, Cancer Che mother Pharmacol, 9, 97, 10.1007/BF00265387 Rohatiner, 1983, Central nervous system toxicity of inter-feron, Br J Cancer, 47, 422, 10.1038/bjc.1983.63 Romano, 1980, Use of human fibroblast-derived (beta) interferon in the treatment of epidemic adenovirus keratoconjunctivitis, J Interferon Res, 1, 169, 10.1089/jir.1980.1.95 Romano, 1983, Clinical effect of human-fibro-blast-derived (beta) interferon in treatment of adenovirus epidemic keratocon junctivitis and its complication, Metab Pediatr Syst Ophthalmol, 7, 31 Rothermel, 1983, Gamma interferon is the factor in lympho-kine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication, J Immunol, 131, 2542, 10.4049/jimmunol.131.5.2542 Rubinstein, 1986, The interferon receptors, CRC Crit Rev Biochemistry, 21, 249, 10.3109/10409238609113613 Sacks, 1982, Antiviral treatment of chronic hepatitis B virus infection: Pharmacokinetics and side effects of interferon and adenine arabi noside alone or in combination, Antimicrob Agents Chemother, 21, 93, 10.1128/AAC.21.1.93 Salmi, 1986, Mechanism of interferon action, J Biol Chem, 261, 16764 Saito, 1985, Prevention from naturally acquired viral respiratory infection by interferon nasal spray, Rhinology, 23, 292 Salazar, 1984, Clinical use of interferons: central nervous system disorders, 472 Sarno, 1984, Intranasally applied recombinant leuko cyte A interferon in normal volunteers. II. Determination of minimal effective and tolerable dose, J Infect Dis, 150, 181, 10.1093/infdis/150.2.181 Samo, 1983, Efficacy and tolerance of intranasally applied recombinant leukocyte A interferon in normal volunteers, J Infect Dis, 148, 535, 10.1093/infdis/148.3.535 Sarkar, 1982, Pharmacokinetic comparison of leukocyte and Escherichia cofe-derived human interferon type alpha, Antiviral Res, 2, 103, 10.1016/0166-3542(82)90030-4 Santoli, 1978, Cell-mediated cytotoxicity in humans against virus-infected target cells. II. Interferon induction and activation of natural killer cells, J Immunol, 121, 5321, 10.4049/jimmunol.121.2.532 Schalm, 1982, Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg-positive chronic active hepatitis: Results of a placebo vs interferon trial, Hepatology, 2, 791, 10.1002/hep.1840020608 Schalm, 1985, Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B, Lancet, 2, 358, 10.1016/S0140-6736(85)92498-5 Schastny'i, 1978, Rational approach to the use of exogenous interferon for prevention of respiratory tract infections among children in medical institutions, Vopr Okhr Materin Det, 23, 87 Schiff G: Personal communication Schönfeld, 1984, Intramuscular human interferon-beta in jections in treatment of condylomata acuminata, Lancet, l, 1038, 10.1016/S0140-6736(84)91450-8 Schouten, 1982, Treatment of juvenile laryngeal papillo matosis with two types of interferon, Laryngoscope, 92, 686, 10.1002/lary.1982.92.6.686 1962, Effect of interferon on vaccination in volun teers, Lancet, 1, 873 1965, Experiments with interferon in man, Lancet, 1, 505 Scott, 1979, Effect of injections of small doses of human fibroblast inter feron into genital warts. A pilot study, Br J Vener Dis, 55, 442 Scott, 1978, Effect of human fibroblast interferon on vaccination in volunteers, J Biol Stand, 6, 73, 10.1016/S0092-1157(78)80036-5 Scott, 1980, Failure of human fibroblast interferon to protect against rhinovirus infection, Arch Virol, 65, 135, 10.1007/BF01317324 Scott, 1982, Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli, Lancet, 2, 186, 10.1016/S0140-6736(82)91031-5 Scott, 1982, Interim report on studies on “toxic” effects of human leucocyte-derived interferon-alpha (HuIFN-a), J Interferon Res, 2, 127, 10.1089/jir.1982.2.127 Scott, 1982, Purified interferon as protection against rhinovirus infection, Br Med J, 284, 1822, 10.1136/bmj.284.6332.1822 Scott, 1985, Tolerance of one-month intranasal interferon, J Med Virol, 17, 99, 10.1002/jmv.1890170202 Scullard, 1979, Effects of human leukocyte interferon on hepatitis B virus replication and immune responses in patients with chronic hepatitis B infection, J Clin Lab Immunol, 1, 277 Scullard, 1981, Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside, J Infect Dis, 143, 772, 10.1093/infdis/143.6.772 Scullard, 1981, Antiviral treatment of chronic hepa titis B virus infection: Improvement in liver disease with interferon and adenine arabinoside, Hepatology, 1, 228, 10.1002/hep.1840010306 Scullard, 1982, Antiviral treatment of chronic hepa titis B virus infection. II. Infectious virus cannot be detected in patient's serum after permanent response to treatment, Hepatology, 2, 39, 10.1002/hep.1840020107 Scully, 1985, Lymphoblastoid interferon therapy of chroni hepatitis B virus infection-different racial responses (abstract), J Hepatol, 2, S328 Sehgal, 1983, Isolation of novel human genomic DNA clones related to human interferon-f51 cDNA, Proc Natl Acad Sci, 80, 3632, 10.1073/pnas.80.12.3632 Sherwin, 1982, A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients, J Am Med Assoc, 248, 2461, 10.1001/jama.1982.03330190025025 Smedley, 1983, Neurological effects of recombinant human interferon, Br Med J, 286, 262, 10.1136/bmj.286.6361.262 Smith, 1983, Synergistic antiviral activity of acyclovir and inter feron on human cytomegalovirus, Antimicrob Agents Chemother, 24, 325, 10.1128/AAC.24.3.325 Smith, 1983, Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection, J Infect Dis, 148, 907, 10.1093/infdis/148.5.907 Smith, 1982, Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection, J Am Med Assoc, 247, 2261, 10.1001/jama.1982.03320410043029 Smith, 1985, Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration, Clin Pharmacol Ther, 37, 85, 10.1038/clpt.1985.16 Solov'ev, 1967, Some results and prospects in the study of endogenous and exogenous interferon, 233 Solov'ev, 1969, The results of controlled observations on the prophylaxis of influenza with interferon, Bull WHO, 41, 683 Soos, 1972, Treatment of local complications provoked by vaccinia virus with leukocytic interferon, 179 Spiegel, 1986, Low incidence of serum neutralizing factors in patients receiving recombinant alpha-2b interferon (Intron A), Am J Med, 80, 223, 10.1016/0002-9343(86)90013-6 Stansfield, 1984, Human leukocyte interferon in the treatment and prophylaxis of acute hemorrhagic conjunctivitis, J Infect Dis, 149, 822, 10.1093/infdis/149.5.822 Stewart, 1981, The pharmacologic properties of various forms of interferon, 25 Strander, 1973, Clinical and laboratory investigations on man: Systemic administration of potent interferon to man, J Natl Cancer Inst, 51, 733, 10.1093/jnci/51.3.733 Strander, 1976, Acute infections in interferon-treated patients with osteosarcoma, J Infect Dis, 133, A245, 10.1093/infdis/133.Supplement_2.A245 Sugar, 1973, Effect of exogenous interferon on herpetic kera titis in rabbits and monkeys, Invest Ophthalmol, 12, 378 Sundmacher, 1976, Interferon in treatment of dendritic keratitis in humans: A preliminary report, J Infect Dis, 133, 160, 10.1093/infdis/133.Supplement_2.A160 Sundmacher, 1976, Successful treatment of dendritic keratitis with human leukocyte interferon, Albrecht Von Graefes Arch Klin Exp Ophthalmol, 201, 39, 10.1007/BF00410146 Sundmacher, 1977, Human-interferon therapy in dendritic keratitis, Ber Zusammenkunft Dtsch Ophthalmol Ges, 74, 615 Sundmacher, 1978, Role of debridement and interferon in the treatment of dendritic keratitis, Albrecht Von Graefes Arch Klin Exp Ophthalmol, 207, 77, 10.1007/BF00414304 Sundmacher, 1978, Human leukocyte and fibroblast inter feron in a combination therapy of dendritic keratitis, Albrecht Von Graefes Arch Klin Exp Ophthalmol, 208, 229, 10.1007/BF00419377 Sundmacher, 1978, Interferon prophylaxis of dendritic kera titis recurrence during local steroid therapy, Ber Zusammenkunft Dtsch Oph thalmol Ges, 75, 344 Sundmacher, 1981, Evaluation of interferon in ocular viral diseases Sundmacher, 1982, The value of exogenous interferon in adenovirus keratoconjunctivitis, Graefe's Arch Clin Exp Ophthalmol, 218, 139, 10.1007/BF02215650 Sundmacher, 1984, Combination therapy for dendritic keratitis. High-titer a-interferon and trifluridine, Arch Ophthalmol, NS102, 554, 10.1001/archopht.1984.01040030432018 Suter, 1984, Electroencephalographic ab normalities in interferon encephalopathy: A preliminary report, Mayo Clin Proc, 59, 847, 10.1016/S0025-6196(12)65620-1 Szoke, 1986, Condyloma acuminatum treated with human leukocyte interferon, J Urology, 135, 1247, 10.1016/S0022-5347(17)46058-7 Taylor, 1985, Nasal interferon responses in leukaemia, Arch Dis Child, 60, 829, 10.1136/adc.60.9.829 Tommila, 1963, Treatment of dendritic keratitis with interferon, Acta Ophthalmol, 41, 478, 10.1111/j.1755-3768.1963.tb03559.x Trent, 1982, Chromosomal localization of human leukocyte, fibro blast, and immune interferon genes by means of in situ hybridization, Proc Natl Acad Sci, 79, 7809, 10.1073/pnas.79.24.7809 Treuner, 1981, Pharmacological aspects of clinical stage I/II trials with human beta interferon in children, J Interferon Res, 1, 373, 10.1089/jir.1981.1.373 Trofatter, 1986, Human lymphoblastoid interferon (Wellferon) in primary therapy of two children with condylomata acuminata, Obstet Gynecol, 67, 137 Turner, 1986, Prevention of experimental coronavirus colds with intranasal a-2b interferon, J Infect Dis, 154, 443, 10.1093/infdis/154.3.443 Tyrrell, 1973, Some possible practical implications of interferon and inter ference, 438 Uyeno, 1982, Interferon treatment of viral warts and some skin diseases Vallbracht, 1981, Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon, Nature, 289, 496, 10.1038/289496a0 Vallbracht, 1985, Hepatitis A virus infection and the interferon system, J Infect Dis, 152, 211, 10.1093/infdis/152.1.211 Vance, 1986, Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris, Arch Dermatol, 122, 272, 10.1001/archderm.1986.01660150050014 Vannini, 1986, Interferon-|3 treatment of herpes simplex keratitis, Basel, Ophthalmologica, 192, 6, 10.1159/000309604 Vesterinen, 1984, Treatment of vaginal flat condyloma with interferon cream, Lancet, 1, 157, 10.1016/S0140-6736(84)90080-1 Vilcek, 1984, Adverse effects of interferon in virus infections, auto-immune diseases and acquired immunodeficiency, Prog Med Virol, 30, 62 Vlatkovic, 1979, Application of human leukocyte interferon in severe cases of virus B hepatitis, 173 Vodopija, 1981, Treatment of persons exposed to rabies with human diploid cell strain rabies vaccine and human leucocyte interferon, Antiviral Res (Abstract, 1, 32 Wade, 1983, Treatment of cytomegaloviral neumonia with high-dose acyclovir and human leukocyte interferon, J Infect Dis, 148, 557, 10.1093/infdis/148.3.557 Week, 1984, Human Lymphoblastoid Interferon, (Wellcome) n the treatment of resistant and recurrent condyloma acuminata (RRCA), Antivai Res, Abstract, 1/3, 97 Weimar, 1977, Fibroblast interferon in HBsAg-positive hronic active hepatitis, Lancet, 2, 1282, 10.1016/S0140-6736(77)92682-4 Weimar, 1978, Double-blind study of interferon dministration in renal transplant recipients, Eur J Clin Invest, 8, 255, 10.1111/j.1365-2362.1978.tb00861.x Weimar, 1979, Differential effects in HBsAg positive hronic active hepatitis, Eur J Clin Invest, 9, 151, 10.1111/j.1365-2362.1979.tb01682.x Weimar, 1979, Prophylactic use of interferon in renal llograft recipients, Transplant Proc, 11, 69 Weimar, 1980, Double-blind study of leukocyte nterferon administration in chronic hepatitis B surface antigen positive hepatitis, Lancet, 1, 336, 10.1016/S0140-6736(80)90885-5 Weimar, 1985, The incidence of cytomegalo-and herpes simplex virus infections in renal allograft recipients treated with high dose recombinant leucocyte interferon: A controlled study, Scan J Urol Nephrol Suppl, 92, 37 Weislow, 1983, Partial purification of a placental interferon with atypical characteristics, J Interferon Res, 3, 291, 10.1089/jir.1983.3.291 Weller, 1982, Inhibition of hepatitis B viral replica tion by lymphoblastoid interferon, Phil Trans R Soc London B, 299, 128, 10.1098/rstb.1982.0114 Wilkinson, 1983, Interferon with novel characteristics produced by human mononuclear leukocytes, Biochem Biophys Res Commun, 111, 498, 10.1016/0006-291X(83)90334-0 Wills, 1984, Interferon kinetics and adverse reactions after intravenous intramuscular and subcutaneous injection, Clin Pharmacol Ther, 35, 722, 10.1038/clpt.1984.101 Wills, 1984, Pharmacokinetics of recombinant alpha A inter feron following IV infusion and bolus, IM, and PO administrations to African green monkeys, J Interferon Res, 4, 399, 10.1089/jir.1984.4.399 Wilson, 1982, Interferon for treatment of subacute sclerosing panencepha litis, Devel Med Chil Neurol, 24, 526, 10.1111/j.1469-8749.1982.tb13661.x Winston, 1983, Safety and tolerance of recombinant leuko cyte A interferon in bone marrow transplant recipients, Antimicrob Agents Chemother, 23, 846, 10.1128/AAC.23.6.846 Wiranowska-Stewart, 1981, Determination of human leukocyte popula tions involved in production of interferons alpha and gamma, J Int Res, 1, 233 Wyler, 1982, Exogenous interferon administration in exper imental Leishmaniasis: In vivo studies, Am J Trop Med Hyg, 3, 740, 10.4269/ajtmh.1982.31.740 Yamamoto, 1986, Human alpha-and beta-interferon but not gamma-suppress the in vitro replication of LAV, HTLV-III, and ARV-2, J Interfer Res, 6, 143, 10.1089/jir.1986.6.143 Yokosuko, 1985, Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: Analysis of intrahepatic replicative hepatitis B virus DNA, Hepatology, 5, 728, 10.1002/hep.1840050505 Yunde, 1978, Effect of radix astragali seu hedysari on the interferon system, Chines Med J, 94, 35 Zenner, 1985, Recombinant interferon-alpha-2C in laryngeal papillomatosis: Preliminary results of a prospective multicenter trial, Oncology, 42, 15, 10.1159/000226079 Zilberstein, 1986, Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimula tory cytokines, EMBO J, 5, 2529, 10.1002/j.1460-2075.1986.tb04531.x Zur Hausen, 1984, Viruses in the etiology of human genital cancer, Prog Med Virol, 30, 170